Children's Hospital of Philadelphia

Researchers Identify “Druggable” Signaling Pathway that Stimulates Lung Tissue Repair

Findings from a CHOP/Penn Medicine study could lead to treatment for patients with lung disease, including acute respiratory distress syndrome due to COVID-19

Newswise — Philadelphia, September 28, 2020—Researchers at Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania have identified a cellular pathway that can be targeted with a naturally occurring drug to stimulate lung tissue regeneration, which is necessary for recovery from multiple lung injuries. The findings, which were published today in Nature Cell Biology, could lead to better therapies for patients with lung disease, including acute respiratory distress syndrome (ARDS) due to COVID-19.

“Using cutting-edge technology, including genome-wide and single-cell analyses, we have identified a specific cellular pathway involved in lung tissue regeneration and found a drug that enhances this process,” said senior author G. Scott Worthen, MD, a physician-scientist in CHOP’s Division of Neonatology and member of the Penn-CHOP Lung Biology Institute. “These findings provide identification of precision targets and thus allow for rational development of therapeutic interventions for lung disease caused by COVID-19 and other illnesses.”

Conditions like pneumonia, influenza and ARDS – one of the known complications of COVID-19 – can damage the lining of the air sacs in the lungs, known as the alveolar epithelium, which prevents oxygen from passing from the lungs to the bloodstream and can lead to death. Patients with COVID-19 who develop ARDS become critically ill, and to date, no drugs have been developed specifically to treat ARDS in COVID-19 patients. Understanding which genetic targets and pathways are involved in regenerating epithelial tissue is critical in developing effective therapies for ARDS and similar conditions.

Previous research has shown that type II alveolar pneumocytes (AT2) are important cells involved in lung repair, both through self-renewal and transdifferentiation into type I alveolar pneumocytes (AT1), which facilitate gas exchange between the lung air sacs and nearby capillaries. Yet prior to this study, it was unknown what changes in gene accessibility occurred in AT2 cells following disease-related injury to promote repair and how regenerating AT2 cells influence interactions with nearby mesenchymal cells, which are also important in tissue repair.

Using genome-wide analyses, the research team assessed changes in AT2 after lung injury, which opens up the chromosomes within the cells and makes specific genes available to the machinery of the cell. The researchers then used single-cell analysis of AT2 cells and mesenchymal cells to better understand how the two cell types interact during injury and what cell signaling pathways are involved. The two approaches converged on a single pathway, in which a transcription factor known as STAT3 increased the expression of brain-derived neurotrophic factor (BDNF), which in turn increased lung tissue regeneration.

In further analyzing this pathway, the researchers identified a naturally-occurring compound known as 7,8-Dihydroflavone (7,8-DHF), which targeted a receptor in the pathway, stimulating and accelerating lung tissue repair in multiple mouse models of lung injury.

“We believe these findings could lead to the development of a new therapeutic that could help patients recovering from COVID-19 and similar diseases,” said the study’s first author, Andrew J. Paris, MD, Instructor of Medicine and a pulmonary specialist in the Perelman School of Medicine at the University of Pennsylvania. “Based on the results of this study, we think 7,8-DHF is an excellent candidate for entering clinical trials for patients with lung diseases.”

The research was supported by the Parker B. Fellowship Program and multiple grants from the National Institutes of Health.

Paris et al. “STAT3-BDNF-TrkB signaling promotes alveolar epithelial regeneration after lung injury,” Nature Cell Biology, September 28, 2020, doi: 10.1038/s41556-020-0569-x

#

About Children’s Hospital of Philadelphia: Children’s Hospital of Philadelphia was founded in 1855 as the nation’s first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals, and pioneering major research initiatives, Children’s Hospital has fostered many discoveries that have benefited children worldwide.  Its pediatric research program is among the largest in the country.  In addition, its unique family-centered care and public service programs have brought the 564-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu

 

 

 

SEE ORIGINAL STUDY




Filters close

Showing results

1120 of 4179
Newswise: 250197_web.jpg
Released: 1-Dec-2020 1:55 PM EST
Mechanism of action of chloroquine/ hydroxychloroquine for COVID-19 infection
Bentham Science Publishers

The recent serious outbreak of Covid19 has affected (November 13, 2020) 53,796,098 people worldwide, resulting in 37,555,669 recovered, 1,310,250 deaths (Figure 1), and a large number of open cases.

Newswise: 250208_web.jpg
Released: 1-Dec-2020 12:45 PM EST
Covid-19 shutdowns disproportionately affected low-income black households
Princeton University

The alarming rate at which Covid-19 has killed Black Americans has highlighted the deeply embedded racial disparities in the U.S. health care system.

Released: 1-Dec-2020 12:25 PM EST
Emergency department doctors ask: "Where did all the patients go?"
Massachusetts General Hospital

During the early days of the COVID-19 pandemic in New England, emergency department visits for medical emergencies - including psychiatric problems, trauma and heart attacks - declined by nearly a third, raising concerns among clinicians that critically ill patients were not seeking the care they needed for fear of coronavirus infection.

Released: 1-Dec-2020 12:05 PM EST
Business closures, partial reopenings due to COVID-19 could cost the US $3-$5 trillion
University of Southern California (USC)

The COVID-19 pandemic could result in net losses from $3.2 trillion and up to $4.8 trillion in U.S. Real Gross Domestic Product (GDP) over the course of two years, a new USC study finds.

Newswise: COVID-19 Story Ideas From Johns Hopkins Medicine
Released: 1-Dec-2020 11:00 AM EST
COVID-19 Story Ideas From Johns Hopkins Medicine
Johns Hopkins Medicine

Johns Hopkins Medicine, together with 100 of the nation’s other top health care systems, representing thousands of hospitals in communities across the U.S., have come together with an urgent plea for all Americans: mask up, because wearing a face mask is one of the best ways to slow the surging COVID-19 pandemic.

Newswise: Out of Many COVID-19 Tests, Which One to Choose?
30-Nov-2020 8:40 AM EST
Out of Many COVID-19 Tests, Which One to Choose?
American Institute of Physics (AIP)

Curbing the coronavirus pandemic relies heavily on how quickly a potentially exposed individual can be tested and quarantined. However, the current diagnostic techniques vary in reliability and relevance, so an understanding of which test is most appropriate for a given circumstance is necessary to avoid false reports. Researchers evaluated the available diagnostic techniques and determined key steps required for better testing moving forward. They present their findings in the journal APL Bioengineering.

30-Nov-2020 2:30 PM EST
CEL-SCI’s Leaps Peptides Demonstrate Clear Survival Benefit as a Treatment for COVID-19 in Preclinical Studies
Cel-Sci Corp

CEL-SCI Corporation announced today its LEAPS COV-19 peptides, delivered as a therapeutic treatment following SARS-CoV-2 virus challenge, achieved a 40% survival rate in transgenic mouse models as compared to 0% survival in the two control groups in studies conducted at the University of Georgia Center for Vaccines and Immunology.

Newswise:Video Embedded reducing-wasteful-medical-care-spending-key-to-reinventing-public-health
VIDEO
Released: 1-Dec-2020 8:45 AM EST
Reducing Wasteful Medical Care Spending: Key to Reinventing Public Health?
American Public Health Association (APHA)

A podcast from the American Journal of Public Health on medical care spending

Newswise: Pets, touch and COVID-19: why our furry friends are lifesavers
Released: 1-Dec-2020 8:40 AM EST
Pets, touch and COVID-19: why our furry friends are lifesavers
University of South Australia

A new study published by University of South Australia researchers points to the lifesaving role that pets have played in 2020 and why governments need to sit up and take notice.


Showing results

1120 of 4179

close
1.0815